< Back to Measuring Value Initiative
​
Expert Panel & Steering Committee Members

Following completion of the literature search and the survey analysis, an expert panel (EP) was convened. The participants can be found below. They represented multiple laboratory specialties, different settings, and a range of positions including administrators, scientists and physicians. Additionally, several non- laboratorians with expertise in measures, maturity models and general healthcare consulting joined the panel.
The agenda for the two-day meeting was ambitious:

• Introduction/Disclosures & Background
• Scope & Definitions
• Domains & Measures
• Framework & Model Development
• Deployment & Evaluation
• Wrap-up & Next steps

After a review of background information, the EP discussed and reached preliminary consensus to associate the output of their work with the label, “High Value Laboratory Medicine.” It was also decided that the final product September 4, 2016 needed to map to both the National Quality Strategy and the Triple Aim to improve understanding with non- laboratorians.
The EP further determined that the profession’s ability to describe its value is not sufficiently advanced to allow forthedevelopmentofarobustsetofdiscretemeasureswithinthetwodaysscheduledforthiswork. A decision to pursue development of a “maturity model.” The work shifted to creating a framework with discrete domains and a hierarchy in which higher levels represented increased delivered value.
The meeting concluded with tentative domains (subsequently changed after the conclusion of the meeting):

1. Evidence-based Utilization Management
2. High Reliability & Patient Safety
3. ​Population Management
4. Leveraging Analytics
5. End-to-End Process Management
6. Generating/Disseminating Knowledge
7. Patient Engagement / Empowerment

For each domain, the EP defined five levels that were characterized by several attribute continuums:

1. Lab-centric to system-centric to patient-centric to patient/population-centric
2. Reactive to proactive
3. Silo’d to integrated
4. Performance evaluation derived from measuring internal processes to measuring outcomes

The EP adjourned with substantial work still needed. Descriptions of each hierarchical level for each domain were generated, but there was no sense that the work was finished. It was agreed that a smaller steering committee (shown in Appendix 4) would continue to meet and further develop the model. The incomplete tasks included finalizing domain names and developing operational descriptions of each level in each domain; creating a narrative that would explain the basis for the model and how it should be applied; and the development of a tool to aid an institution in assessing its current performance level with a visual read-out (spider diagram). 

Expert Panelists
Erik Baldwin MBA, MT(ASCP)DLMCM, FACHE, CPHQ , Director of Accreditation, Regulation and Licensure for the Mid-Atlantic Region, Kaiser
Adam Birks CLS, MLS (ASCP), Laboratory Director, Kalispell Regional Medical Center Laboratory
Michael Davis, MS, MBA, Principal at Davis Business Advisory, LLC
Paul Epner, MBA, M.Ed. Executive Vice President, Society to Improve Diagnosis in Medicine
Eleanor Herriman, M.D., M.B.A., Chief Medical Informatics Officer, Viewics, Inc.
Chris Hubble, MD, Consultant at Healthcare Performance Improvement (HPI)
Brian R. Jackson, MD, MS, Vice President and Chief Medical Informatics Officer, ARUP Laboratories Assoc. Professor of Pathology (Clinical), University of Utah
David D. Koch, Ph.D., DABCC, FACB, Professor of Pathology, Emory University and Director of Clinical Chemistry, Toxicology, and Point-of-Care Testing, Grady Memorial Hospital
Diana L. Kremitske MHA, MS, MT(ASCP), VP Laboratory Operations, Geisinger Health System
Bozena Labuda, MT(ASCP), CHS(ABHI), Manager, Histocompatibility Laboratory, Histocompatibility & Immunogenetics Laboratory, Gift of Hope Organ & Tissue Donor Network
Andrew Lyzenga, Senior Director, Quality Measurement, National Quality Forum
Susan Morris, MPH, MLS(ASCP)CM, Patient Safety Officer, St. Luke’s Magic Valley Medical Center
Elissa Passiment, M.Ed., Executive Vice President of the American Society for Clinical Laboratory Science (ASCLS)
Edward J. Peterson, Jr., MBA, MT(ASCP), Director of Laboratories, Barnes-Jewish Hospital
Khosrow Shobotani, Chief Executive Officer, TriCore Reference Laboratories
Michele Smith, MS, SCT(ASCP), Program Director, Cytotechnology Program; Manager, Cytology Services, University of Wisconsin-Madison, Wisconsin State Laboratory of Hygiene
Sam Terese, MBA, MT(ASCP), Chief Executive Officer and President of PCL Alverno
Eva Wojcik, MD, Chair of Pathology, Department of Pathology and Urology, Medical Director of Clinical Laboratories, Loyola University Medical Center Expert Panel & Steering Committee Members

Steering Committee
Michael Davis, MS, MBA, Principal at Davis Business Advisory, LLC
Paul Epner, MBA, M.Ed. Executive Vice President, Society to Improve Diagnosis in Medicine
Julie Gayken, MT(ASCP), CLC(AMT), Senior Director of Laboratory Services (retired), HealthPartners (Minnesota)
Chris Hubble, MD, Consultant at Healthcare Performance Improvement (HPI)
Brian R. Jackson, MD, MS, Vice President and Chief Medical Informatics Officer, ARUP Laboratories Assoc.
Professor of Pathology (Clinical), University of Utah
David D. Koch, Ph.D., DABCC, FACB, Professor of Pathology, Emory University and Director of Clinical Chemistry, Toxicology, and Point-of-Care Testing, Grady Memorial Hospital
Diana L. Kremitske MHA, MS, MT(ASCP), VP Laboratory Operations, Geisinger Health System
Andrew Lyzenga, Senior Director, Quality Measurement, National Quality Forum
Stacy Melanson, MD, PhD, Associate Medical Director, Clinical Chemistry, Medical Director of Phlebotomy, Assistant Professor, Harvard Medical School